Release of Draft (Step 2) International Council for Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) Guidance: E17: General principles on planning/designing Multi-Regional Clinical Trials
The above referenced draft guidance was released by the ICH Steering Committee for consultation and is being posted on the ICH website for information and comment in accordance with Step 2 of the ICH process.
How to Get Involved
This consultation is open for comment starting July 29, 2016 until October 27, 2016. Please select and read through the link below titled "consultation document". Once read, please submit your comments via email, fax or by mail to:
Health Canada ICH Secretariat
Bureau of Policy, Science and International Programs
Therapeutic Products Directorate
Health Products and Food Branch
Health Canada
1600 Scott Street, Tunney's Pasture
Ottawa, Ontario
K1A 0K9
E-mail: HPFB_ICH_DGPSA@hc-sc.gc.ca
Telephone: 613-698-9178
Facsimile: 613-941-1812
Interested parties are encouraged to provide comments and suggestions by October 27, 2016.
Reporting to Canadians
Health Canada will make the results of this consultation available on this Web site.
If you have any questions, contact Health Canada ICH Secretariat.
Interested in our other consultations? Sign up and stay informed about topics that matter to you.